Skip to main content
WeRide Inc. logo

WeRide Inc. — Investor Relations & Filings

Ticker · 800 LEI · 254900R1B7IWBCPDQ262 HKEX Transportation and storage
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2008-07-18 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 800

About WeRide Inc.

http://www.weride.ai

WeRide Inc. is a commercial-stage global technology leader specializing in the research, development, and large-scale deployment of autonomous driving solutions, ranging from Level 2 (WePilot 3.0 ADAS) to Level 4 capabilities. The company offers a comprehensive portfolio of autonomous vehicles designed for various mobility and logistics applications, including Robotaxi, Robobus, Robovan, and Robosweeper. WeRide is recognized as a pioneer in the industry, operating in over 40 cities across 11 countries and holding autonomous driving permits in seven countries globally. Its core products, such as the Robotaxi, have launched large-scale commercial operations in regions like China and the UAE. WeRide leverages its proprietary technology stack to deliver safe, reliable, and scalable driverless solutions for urban transformation.

Recent filings

Filing Released Lang Actions
CHANGE OF PRINCIPAL PLACE OF BUSINESS
Regulatory Filings Classification · 95% confidence The document is a short announcement from the board of directors about a change in the company's principal place of business. It does not contain financial data, audit information, or detailed management discussion. It is an official announcement related to company operations but not related to board or management changes in personnel. The document length is only 1089 characters, indicating it is a brief notice. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2008-07-18 English
CHANGE OF BOARD LOT SIZE
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Far East Pharmaceutical Technology Company Limited regarding a change in the board lot size of its shares for trading on the Stock Exchange. It references previous circulars and announcements and provides details about the effective date and matching services for odd lots. The document is short (3332 characters) and serves as an informational announcement about a capital structure change (board lot size adjustment). It does not contain financial statements, management discussion, or detailed financial data. Therefore, it is not an Annual Report, Interim Report, or Earnings Release. It is also not a report publication announcement since it does not mention the release of a report. The content fits best under the category of Share Issue/Capital Change (SHA), as it relates to changes in share trading units, which is a capital structure matter.
2008-07-18 English
EXCHANGE NOTICE - RESUMPTION OF TRADING
Regulatory Filings Classification · 95% confidence The document is a short exchange notice regarding the resumption of trading for a specific stock. It does not contain financial statements, management reports, or other substantive disclosures, but rather serves as a regulatory notification regarding market activity. As it does not fit into specific categories like M&A or share issues, it falls under the general regulatory filing category.
2008-07-18 English
DISCHARGE OF PROVISIONAL LIQUIDATORS,COMPLETION OF PLACING DOWN AND RESUMPTION OF TRADING
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the discharge of provisional liquidators, completion of a placing down agreement (a share placement), and the resumption of trading of the company's shares. It includes details about the placing down agreement, shareholding structure before and after the placing, and the resumption of trading on the stock exchange. There are no financial statements, quarterly or annual results, or detailed financial analysis present. The document is primarily about a capital raising event and related corporate actions. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive information about the placing down and shareholding changes, not just a brief announcement or a link to a report, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2008-07-17 English
COMPLETION OF ALL CONDITIONS SET OUT IN THE DECISION LETTER
Capital/Financing Update Classification · 95% confidence The document is an announcement from Far East Pharmaceutical Technology Company Limited regarding the completion of conditions set out in a Decision Letter from the Stock Exchange of Hong Kong, related to the resumption of trading after a period of suspension and delisting procedures. It details compliance with restructuring agreements, court orders, shareholding structure changes, appointment of new directors, and other corporate actions. The document is lengthy (15,000 characters) and contains detailed information about corporate restructuring, share placements, and director appointments. It is not a full financial report like an Annual Report or Interim Report, nor is it a simple announcement of a report publication. It is primarily an update on capital restructuring, share placements, and related corporate governance matters. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2008-07-10 English
INTERIM REPORT FOR THE SIX MONTHS ENDED 31 DECEMBER 2006
Regulatory Filings
2008-07-03 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.